Chindia Generics: A Dream or Reality?
Meeting and greeting is necessary, as is the right form of partnership and getting everyone on board. But as Indian drug makers learn the ropes of entering the complex Chinese market, the seemingly natural fit may still have a long way to go.
You may also be interested in...
China Vs. Cancer: Seven Companies Given Price Cuts, Roche Gets New Approval
Cancer drug prices again on the chopping board in China, including for some products already affected, and more are coming.
Home Gains Buoy Cipla In Q1 But US Momentum Pivotal
A strong run on home turf lifted Cipla in Q1, but US momentum with differentiated launches is what investors are keeping a sharp eye on. A China play in the respiratory space is also on the cards for the Indian firm.
Downward, Eastward or Inward? Blockbuster Film Puts Cancer Drug Prices In China Spotlight
Bagging a $200m box office in its opening week in China, "Dying to Survive" is a sentimental movie about a Chinese businessman selling cancer drugs smuggled from India but unapproved in China that sees his life taking a drastic turn, from convicted felon to a Robin Hood-like hero as he helps those in need. The Chinese film authority’s clearance for the screening of the movie and the smash success signal three key messages about the future potential direction of oncology drugs in the country.